Literature DB >> 30520725

A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV.

Molly OhAinle1, Louisa Helms1, Jolien Vermeire1, Ferdinand Roesch1, Daryl Humes1, Ryan Basom2, Jeffrey J Delrow2, Julie Overbaugh1, Michael Emerman1.   

Abstract

Interferon (IFN) inhibits HIV replication by inducing antiviral effectors. To comprehensively identify IFN-induced HIV restriction factors, we assembled a CRISPR sgRNA library of Interferon Stimulated Genes (ISGs) into a modified lentiviral vector that allows for packaging of sgRNA-encoding genomes in trans into budding HIV-1 particles. We observed that knockout of Zinc Antiviral Protein (ZAP) improved the performance of the screen due to ZAP-mediated inhibition of the vector. A small panel of IFN-induced HIV restriction factors, including MxB, IFITM1, Tetherin/BST2 and TRIM5alpha together explain the inhibitory effects of IFN on the CXCR4-tropic HIV-1 strain, HIV-1LAI, in THP-1 cells. A second screen with a CCR5-tropic primary strain, HIV-1Q23.BG505, described an overlapping, but non-identical, panel of restriction factors. Further, this screen also identifies HIV dependency factors. The ability of IFN-induced restriction factors to inhibit HIV strains to replicate in human cells suggests that these human restriction factors are incompletely antagonized. Editorial note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that all the issues have been addressed (see decision letter).
© 2018, OhAinle et al.

Entities:  

Keywords:  CRISPR; HIV; infectious disease; interferon-stimulated genes; microbiology; restriction factor; screen; virus; virus replication

Mesh:

Substances:

Year:  2018        PMID: 30520725      PMCID: PMC6286125          DOI: 10.7554/eLife.39823

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  119 in total

1.  An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus.

Authors:  S Gummuluru; C M Kinsey; M Emerman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Identifying differentially expressed genes using false discovery rate controlling procedures.

Authors:  Anat Reiner; Daniel Yekutieli; Yoav Benjamini
Journal:  Bioinformatics       Date:  2003-02-12       Impact factor: 6.937

3.  Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein.

Authors:  Guangxia Gao; Xuemin Guo; Stephen P Goff
Journal:  Science       Date:  2002-09-06       Impact factor: 47.728

4.  Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection.

Authors:  Hong-Liang Liu; Yin-Qiu Wang; Cheng-Hong Liao; Yi-Qun Kuang; Yong-Tang Zheng; Bing Su
Journal:  Gene       Date:  2005-10-13       Impact factor: 3.688

5.  Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.

Authors:  M Poss; J Overbaugh
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

7.  Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication.

Authors:  Ozlem Equils; Marco L Schito; Hiase Karahashi; Zeynep Madak; Ayse Yarali; Kathrin S Michelsen; Alan Sher; Moshe Arditi
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

8.  Retinoblastoma protein purification and transduction of retina and retinoblastoma cells using improved alphavirus vectors.

Authors:  David P DiCiommo; Allison Duckett; Irina Burcescu; Rod Bremner; Brenda L Gallie
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

9.  Expression of the zinc-finger antiviral protein inhibits alphavirus replication.

Authors:  Matthew J Bick; John-William N Carroll; Guangxia Gao; Stephen P Goff; Charles M Rice; Margaret R MacDonald
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

View more
  37 in total

Review 1.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

Review 2.  Species-Specific Host-Virus Interactions: Implications for Viral Host Range and Virulence.

Authors:  Stefan Rothenburg; Greg Brennan
Journal:  Trends Microbiol       Date:  2019-10-06       Impact factor: 17.079

Review 3.  Restriction of HIV-1 and other retroviruses by TRIM5.

Authors:  Barbie K Ganser-Pornillos; Owen Pornillos
Journal:  Nat Rev Microbiol       Date:  2019-07-16       Impact factor: 60.633

4.  The Role of Long Noncoding RNA BST2-2 in the Innate Immune Response to Viral Infection.

Authors:  Shengwen Chen; Xiang Huang; Qinya Xie; Qian Liu; Haizhen Zhu
Journal:  J Virol       Date:  2022-03-17       Impact factor: 6.549

5.  HIV-CRISPR: A CRISPR/Cas9 Screening Method to Identify Genes Affecting HIV Replication.

Authors:  Ferdinand Roesch; Molly OhAinle
Journal:  Bio Protoc       Date:  2020-05-05

6.  Differential Inhibition of HIV Replication by the 12 Interferon Alpha Subtypes.

Authors:  Armando Espinosa Ortiz; Olivia Blake; Alexandra Tauzin; Calaiselvy Soundaramourty; Charles Joly-Beauparlant; Alexandre Nicolas; Arnaud Droit; Jacques Dutrieux; Jérôme Estaquier; Fabrizio Mammano
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

7.  HIV envelope tail truncation confers resistance to SERINC5 restriction.

Authors:  Tafhima Haider; Xenia Snetkov; Clare Jolly
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 12.779

Review 8.  Discovering antiviral restriction factors and pathways using genetic screens.

Authors:  Chloe E Jones; Wenfang S Tan; Finn Grey; David J Hughes
Journal:  J Gen Virol       Date:  2021-05       Impact factor: 3.891

9.  Germline SAMD9L truncation variants trigger global translational repression.

Authors:  Troy R Torgerson; David J Rawlings; Eric J Allenspach; Frank Soveg; Laura S Finn; Lomon So; Jacquelyn A Gorman; Aaron B I Rosen; Suzanne Skoda-Smith; Marsha M Wheeler; Kaitlyn A Barrow; Lucille M Rich; Jason S Debley; Michael J Bamshad; Deborah A Nickerson; Ram Savan
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

10.  Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the Viral Core.

Authors:  Anastasia Selyutina; Mirjana Persaud; Lacy M Simons; Angel Bulnes-Ramos; Cindy Buffone; Alicia Martinez-Lopez; Viviana Scoca; Francesca Di Nunzio; Joseph Hiatt; Alexander Marson; Nevan J Krogan; Judd F Hultquist; Felipe Diaz-Griffero
Journal:  Cell Rep       Date:  2020-03-17       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.